Refractive Surgery News

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Yari L. Mitchell discusses new technologies for presbyopia correction.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Erik Mertens, MD, discusses his long-term experience implanting the STAAR Surgical EVO Visian ICL to correct myopia.

WASHINGTON — Topography is a valuable tool to detect corneal irregularity and asymmetry, a speaker said during Refractive Day at the American Society of Cataract and Refractive Surgery meeting.

WASHINGTON — Stable and predictable healing of the epithelium is important for achieving positive refractive surgery outcomes, according to a speaker here.

Toric IOLs are an invaluable tool in the cataract surgeon’s armamentarium, not difficult to use and beneficial for the practice and patients, according to one presenter.

Twice-daily Vuity for presbyopia met its primary efficacy endpoint in the phase 3 VIRGO trial, according to a press release from Allergan/AbbVie.

In a second phase 3 registration trial, Nyxol helped reverse pharmacologically induced mydriasis at 90 minutes, according to a press release from Ocuphire Pharma.

The FDA approved the EVO/EVO+ Visian implantable Collamer lens for the correction of myopia and myopia with astigmatism, according to a press release from STAAR Surgical.

ORLANDO — In this Healio Video Perspective from Cataract Surgery: Telling It Like It Is, George O. Waring IV, MD, FACS, discusses an update to the Catalys Precision laser system from Johnson & Johnson Vision.

Vuity, an eye drop for the treatment of presbyopia, is now available, according to a press release from AbbVie.